Advanced Therapies Congress
https://www.terrapinn.com/congress/advanced-therapies-usa/index.stm
Date: November 18-19, 2025
Location: Philadelphia Convention Center,
Philadelphia, PA
JOIN US!
Catalent is excited to participate in Advanced Therapies Congress USA 2025.
From early-stage development to full-scale commercialization, we partner with leading cell & gene therapy innovators to tackle the most complex challenges — and we’re honored to contribute to this year’s program.
Connect with our cell & gene therapy experts to explore how Catalent can advance your program!
Don’t miss our expert speaking session ……
Complete the form to schedule a meeting with our experts!
SPEAKING ENGAGEMENTS
Date/Time: 2:55 – 3:15 PM, November 18, 2025
Speaker: Philip Wills, Chief Commercial Officer,
Catalent Cell & Gene Therapy
Title: Unpacking FDA’s Platform Technology Designation Program: Key Considerations for Sponsors Partnering with CDMOs
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. www.catalent.com.
